Funded agtech is the first payer.
Test
A named startup pays.
Falsifier
Multiple strong adopters refuse the commercial plane.
Commercial falsification matrix
The commercial claims get exactly the same treatment as the technical ones.
The Evidence Plane creates recurring value.
Test
Renewal, maintained programme, or ongoing evaluation.
Falsifier
All value occurs during implementation.
Downstream requirements create pull.
Test
A recipient requests portable evidence.
Falsifier
The company has to manufacture demand entirely itself.
The open SDK lowers acquisition cost.
Test
External adoption precedes the enterprise sales process.
Falsifier
Every integration requires a founder-led enterprise sale.
Objection room
Objection → answer → evidence required → status
ObjectionOpen
Another interoperability standard nobody adopts.
Management answer
Adoption begins with local developer utility and specific evidence flows, not industry consensus.
Evidence required
SDK activationArtifact productionExternal useSecond-company reuse
ObjectionOpen
The open layer just becomes a public good.
Management answer
The commercial surface is operation, not access. Self-operation is allowed and expected to be unattractive at scale.
Evidence required
A customer able to self-operate the open layer who still pays for managed operation
ObjectionOpen
Nobody will pay.
Management answer
The first payer is the funded agtech crossing an institutional boundary, not the institution.
Evidence required
Paid readinessPaid bridge or deploymentAnnual recurring operation
ObjectionOpen
An incumbent can copy this.
Management answer
The software is copyable. Neutrality, while running a vertically integrated platform, is not.
Evidence required
Independent technologies adopting the neutral interface despite vertical alternatives
ObjectionOpen
This is consulting.
Management answer
Then deployment hours will not fall and reuse will not rise. Both are instrumented from customer one.
Evidence required
Deployment hours fallingReuse risingManaged ARR rising
ObjectionOpen
The founder cannot turn this into an institution.
Management answer
Delegation is a gate, not an aspiration, and it is measured at month 12.
Evidence required
Deployment delegatedCustomer cadence delegatedDocumented operating processCustomers renewing without the founder as every interface
Objections are only useful once they are measurable. Each one above names the observation that would settle it.
Independent review
Everything in this room
Related views
Independent is the verification index over the other three
Commercial proof standard
Does a funded agtech pay to cross a real evidence boundary? Does the Evidence Plane create recurring operational value after implementation? Does a downstream institution request a portable artifact? Does the second deployment require fewer hours? Do profiles and connectors become reusable assets?
These are the observations that distinguish a product business from an elegant architecture.
Reading through Overall
The native reading. Claim status, evidence burden, proof gates, falsifiers, contradictions, capital-to-proof, governance, downside, and explicit reasons to stop or narrow the thesis.